A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension.
Phase of Trial: Phase II
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Candesartan cilexetil/nifedipine (Primary) ; Candesartan cilexetil; Nifedipine
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms DISTINCT
- Sponsors Bayer
- 11 Aug 2016 Results of subgroup analysis published in the Journal of Human Hypertension
- 01 Feb 2016 Subgroup analysis (n=1362) published in the Journal of Clinical Pharmacology.
- 11 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History